---
figid: PMC7730176__ijms-21-09114-g003
figlink: pmc/articles/PMC7730176/figure/ijms-21-09114-f003/
number: Figure 3
caption: Estrogen and anti-estrogen signaling in glioblastoma. Glioblastoma cells
  are sensitive to exogenous 17β-estradiol (E2) and 2-methoxyestradiol (2-ME) and
  the anti-estrogen tamoxifen (TAM) exposure through ERβ1, 2, 5 and ERα36 receptors
  that trigger non-genomic signaling. Tamoxifen-induced ERα36-dependent pathway involves
  PI3K-Akt and mTOR signaling to enhance autophagy and resistance to anti-cancer therapy.
  In the presence of 17β-estradiol or 2-methoxyestradiol, ERβ1 and ERβ5 nuclear receptors
  stimulate mTOR, JAK/STAT, NF-kB or JNK signaling to impact cancer cell proliferation,
  migration/invasion, survival or resistance to chemotherapy or may directly modulate
  the expression of their target genes. ERβ2 isoform is expressed in most glioblastoma
  cell lines or patient tumor samples but the downstream signaling remains to be determined.
  Endogenous production of estrogens by aromatase may be stimulated by an enhanced
  expression of the enzyme through vitamin D (VD), mifepristone (RU486) or dexamethasone
  (DEX) exposure, leading to increased tumor cell proliferation whereas the administration
  of letrozole (LET), a competitive inhibitor of aromatase activity, results in tumor
  volume reduction.
pmcid: PMC7730176
papertitle: 'Astrocytoma: A Hormone-Sensitive Tumor?.'
reftext: Alex Hirtz, et al. Int J Mol Sci. 2020 Dec;21(23):9114.
pmc_ranked_result_index: '23478'
pathway_score: 0.9687912
filename: ijms-21-09114-g003.jpg
figtitle: Estrogen and anti-estrogen signaling in glioblastoma
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7730176__ijms-21-09114-g003.html
  '@type': Dataset
  description: Estrogen and anti-estrogen signaling in glioblastoma. Glioblastoma
    cells are sensitive to exogenous 17β-estradiol (E2) and 2-methoxyestradiol (2-ME)
    and the anti-estrogen tamoxifen (TAM) exposure through ERβ1, 2, 5 and ERα36 receptors
    that trigger non-genomic signaling. Tamoxifen-induced ERα36-dependent pathway
    involves PI3K-Akt and mTOR signaling to enhance autophagy and resistance to anti-cancer
    therapy. In the presence of 17β-estradiol or 2-methoxyestradiol, ERβ1 and ERβ5
    nuclear receptors stimulate mTOR, JAK/STAT, NF-kB or JNK signaling to impact cancer
    cell proliferation, migration/invasion, survival or resistance to chemotherapy
    or may directly modulate the expression of their target genes. ERβ2 isoform is
    expressed in most glioblastoma cell lines or patient tumor samples but the downstream
    signaling remains to be determined. Endogenous production of estrogens by aromatase
    may be stimulated by an enhanced expression of the enzyme through vitamin D (VD),
    mifepristone (RU486) or dexamethasone (DEX) exposure, leading to increased tumor
    cell proliferation whereas the administration of letrozole (LET), a competitive
    inhibitor of aromatase activity, results in tumor volume reduction.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - AKT2
  - AKT3
  - AKT1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - STAT3
  - JUN
  - TF
  - TAM
  - RU486
  - DEX
genes:
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
chemicals:
- word: TAM
  source: MESH
  identifier: C419191
- word: RU486
  source: MESH
  identifier: D015735
- word: DEX
  source: MESH
  identifier: C534732
diseases: []
---
